Showing results (721-730 of 791) with videos related to

Sort By:
Pageof 80
JAMA Neurology|August 15, 2022
Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A ReviewHugh S Markus, Wiesje M van Der Flier, Eric E Smith, et al.
Brain : a Journal of Neurology|March 25, 2024
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementiaLianne M Reus, Iris E Jansen, Betty M Tijms, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairmentAnna E Leeuwis, Astrid M Hooghiemstra, Raquel Amier, et al.
The Journal of Prevention of Alzheimer'S Disease|March 18, 2025
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilitiesGiovanni B Frisoni, Federica Ribaldi, Gilles Allali, et al.
Neurobiology of Aging|June 13, 2016
ABCA7 p.G215S as potential protective factor for Alzheimer's diseaseCeleste Sassi, Michael A Nalls, Perry G Ridge, et al.
Neurology|July 2, 2021
[18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic CarriersEmma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2018
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementiaRosalinde E R Slot, Sietske A M Sikkes, Johannes Berkhof, et al.
Human Molecular Genetics|July 17, 2014
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's diseaseAlfredo Ramirez, Wiesje M van der Flier, Christine Herold, et al.
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Pageof 80